SlideShare a Scribd company logo
Entity Relationship Diagrams
 
 
 
Prescription
Prescription
Prescription Dr. Lewis Zimmerman 459  Patient name: Tom Paris Stardate: 41153.7  Drug: Tri-Ox Compound Take twice a day Dr. Lewis Zimmerman 459  Patient name: Tom Paris Stardate: 41153.7  Drug: Tri-Ox Compound Take twice a day
Prescription Dr. Lewis Zimmerman 459  Patient name: Tom Paris Stardate: 41153.7  Drug: Tri-Ox Compound Take twice a day Doctor Patient Date Drug Frequency Prescription number Dr. Lewis Zimmerman 459  Patient name: Tom Paris Stardate: 41153.7  Drug: Tri-Ox Compound Take twice a day
Prescription PrescriptionID DoctorName PatientName DrugName Date Frequency
Prescription PrescriptionID DoctorName PatientName DrugName Date Frequency Is this a good and sufficient representation ?????
Prescription 3 37389.5 Tri-Ox T’Pol Dr. Phlox 9 4 45673.4 Hyronalin Katherine Janeway Dr. L.  Zimmerman 8 5 42604.4 Tri-Ox Tom Paris Dr. Lewis Zimmerman 7 90 42765.5 Priaxate Tom Paris L. Zimmerman 6 2 48796.6 Synaptizine Odo Dr. Bashir 5 1 45912.3 Hyronalin Lt. Data Dr. Beverly Crusher 4 7 42235.2 Tri-Ox Harry Kim Lewis Zimmerman 3 3 45432.1 Hyronalin Odo Dr. Julian Bashir 2 2 42231.2 Tri-Ox Tom Paris Dr. Lewis Zimmerman  1 Frequency (per day) Date Drug Name Patient Name Doctor Name Prescription ID
[object Object],[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object],Doctor Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman  1 Doctor Name Doctor ID
Prescription 3 37389.5 Tri-Ox T’Pol Dr. Phlox 9 4 45673.4 Hyronalin Katherine Janeway Dr. L.  Zimmerman 8 5 42604.4 Tri-Ox Tom Paris Dr. Lewis Zimmerman 7 90 42765.5 Priaxate Tom Paris L. Zimmerman 6 2 48796.6 Synaptizine Odo Dr. Bashir 5 1 45912.3 Hyronalin Lt. Data Dr. Beverly Crusher 4 7 42235.2 Tri-Ox Harry Kim Lewis Zimmerman 3 3 45432.1 Hyronalin Odo Dr. Julian Bashir 2 2 42231.2 Tri-Ox Tom Paris Dr. Lewis Zimmerman  1 Frequency (per day) Date Drug Name Patient Name Doctor Name Prescription ID
Prescription 3 37389.5 Tri-Ox T’Pol 4 9 4 45673.4 Hyronalin Katherine Janeway 1 8 5 42604.4 Tri-Ox Tom Paris 1 7 90 42765.5 Priaxate Tom Paris 1 6 2 48796.6 Synaptizine Odo 2 5 1 45912.3 Hyronalin Lt. Data 2 4 7 42235.2 Tri-Ox Harry Kim 1 3 3 45432.1 Hyronalin Odo 2 2 2 42231.2 Tri-Ox Tom Paris 1  1 Frequency (per day) Date Drug Name Patient Name Doctor ID Prescription ID
[object Object],[object Object],Patient T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID
Prescription 3 37389.5 Tri-Ox T’Pol 4 9 4 45673.4 Hyronalin Katherine Janeway 1 8 5 42604.4 Tri-Ox Tom Paris 1 7 90 42765.5 Priaxate Tom Paris 1 6 2 48796.6 Synaptizine Odo 2 5 1 45912.3 Hyronalin Lt. Data 2 4 7 42235.2 Tri-Ox Harry Kim 1 3 3 45432.1 Hyronalin Odo 2 2 2 42231.2 Tri-Ox Tom Paris 1  1 Frequency (per day) Date Drug Name Patient Name Doctor ID Prescription ID
Prescription 3 37389.5 Tri-Ox 6 4 9 4 45673.4 Hyronalin 5 1 8 5 42604.4 Tri-Ox 1 1 7 90 42765.5 Priaxate 1 1 6 2 48796.6 Synaptizine 2 2 5 1 45912.3 Hyronalin 4 2 4 7 42235.2 Tri-Ox 3 1 3 3 45432.1 Hyronalin 2 2 2 2 42231.2 Tri-Ox 1 1  1 Frequency (per day) Date Drug Name Patient ID Doctor ID Prescription ID
[object Object],[object Object],Drug Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID
Prescription 3 37389.5 Tri-Ox 6 4 9 4 45673.4 Hyronalin 5 1 8 5 42604.4 Tri-Ox 1 1 7 90 42765.5 Priaxate 1 1 6 2 48796.6 Synaptizine 2 2 5 1 45912.3 Hyronalin 4 2 4 7 42235.2 Tri-Ox 3 1 3 3 45432.1 Hyronalin 2 2 2 2 42231.2 Tri-Ox 1 1  1 Frequency (per day) Date Drug Name Patient ID Doctor ID Prescription ID
Prescription 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1  1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID
[object Object]
Prescription Drug Patient Doctor 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1  1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman  1 Doctor Name Doctor ID
Prescription Drug Patient Doctor
[object Object],[object Object]
Prescription Drug Patient Doctor 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1  1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman  1 Doctor Name Doctor ID
Prescription Drug Patient Doctor Text Numbers Text Text 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1  1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman  1 Doctor Name Doctor ID
Prescription Drug Patient Doctor Transactional Table Master Table Master Table Master Table 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1  1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman  1 Doctor Name Doctor ID
[object Object],[object Object]
Prescription Drug Patient Doctor 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1  1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman  1 Doctor Name Doctor ID
Prescription Drug Patient Doctor Tricordrazine 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1  1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman  1 Doctor Name Doctor ID
[object Object]
Prescription 3 37389.5 Tri-Ox T’Pol Dr. Phlox 9 4 45673.4 Hyronalin Katherine Janeway Dr. L.  Zimmerman 8 5 42604.4 Tri-Ox Tom Paris Dr. Lewis Zimmerman 7 90 42765.5 Priaxate Tom Paris L. Zimmerman 6 2 48796.6 Synaptizine Odo Dr. Bashir 5 1 45912.3 Hyronalin Lt. Data Dr. Beverly Crusher 4 7 42235.2 Tri-Ox Harry Kim Lewis Zimmerman 3 3 45432.1 Hyronalin Odo Dr. Julian Bashir 2 2 42231.2 Tri-Ox Tom Paris Dr. Lewis Zimmerman  1 Frequency (per day) Date Drug Name Patient Name Doctor Name Prescription ID
Prescription Tricordrazine Tricordrazine Tricordrazine Tricordrazine 3 37389.5 Tri-Ox T’Pol Dr. Phlox 9 4 45673.4 Hyronalin Katherine Janeway Dr. L.  Zimmerman 8 5 42604.4 Tri-Ox Tom Paris Dr. Lewis Zimmerman 7 90 42765.5 Priaxate Tom Paris L. Zimmerman 6 2 48796.6 Synaptizine Odo Dr. Bashir 5 1 45912.3 Hyronalin Lt. Data Dr. Beverly Crusher 4 7 42235.2 Tri-Ox Harry Kim Lewis Zimmerman 3 3 45432.1 Hyronalin Odo Dr. Julian Bashir 2 2 42231.2 Tri-Ox Tom Paris Dr. Lewis Zimmerman  1 Frequency (per day) Date Drug Name Patient Name Doctor Name Prescription ID
[object Object]
Prescription Tricordrazine Tricordrazine Tricordrazine 3 37389.5 Tri-Ox T’Pol Dr. Phlox 9 4 45673.4 Hyronalin Katherine Janeway Dr. L.  Zimmerman 8 5 42604.4 Tri-Ox Tom Paris Dr. Lewis Zimmerman 7 90 42765.5 Priaxate Tom Paris L. Zimmerman 6 2 48796.6 Synaptizine Odo Dr. Bashir 5 1 45912.3 Hyronalin Lt. Data Dr. Beverly Crusher 4 7 42235.2 Tri-Ox Harry Kim Lewis Zimmerman 3 3 45432.1 Hyronalin Odo Dr. Julian Bashir 2 2 42231.2 Tri-Ox Tom Paris Dr. Lewis Zimmerman  1 Frequency (per day) Date Drug Name Patient Name Doctor Name Prescription ID
[object Object],[object Object]
[object Object]
Prescription Drug Patient Doctor 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1  1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman  1 Doctor Name Doctor ID
Now when we insert a record
Now when we insert a record PrescriptionID DoctorID PatientID DrugID Date Frequency
Prescription Insert new prescription record
Prescription Insert new prescription record Drug Check if the drug on the prescription is a real and existing drug
Prescription Drug Insert new prescription record Patient Check if the patient on the prescription is a real and existing patient
Prescription Drug Insert new prescription record Patient Check if the doctor  on the Prescription  is a real and  existing doctor Doctor
Prescription Drug Patient Doctor
Prescription Drug Patient Doctor DrugID PatientID DoctorID
Prescription Drug Patient Doctor DrugID PatientID DoctorID PrescriptionID DoctorID PatientID DrugID Date Frequency DrugID DrugName RecommendedDosage Side-Effects PatientID PatientName PatientAddress Sympthoms Occupation DoctorID DoctorName Qualifications
Prescription Drug Patient Doctor DrugID PatientID DoctorID PrescriptionID DoctorID PatientID DrugID Date Frequency DrugID DrugName RecommendedDosage Side-Effects DoctorID DoctorName Qualifications PatientID PatientName PatientAddress Sympthoms Occupation
 

More Related Content

Viewers also liked

Bridge metrics channel marketing overview 2013
Bridge metrics channel marketing overview 2013Bridge metrics channel marketing overview 2013
Bridge metrics channel marketing overview 2013Chris May
 
Corporate training - Mind Programming - Kushalta Academy
Corporate training - Mind Programming - Kushalta AcademyCorporate training - Mind Programming - Kushalta Academy
Corporate training - Mind Programming - Kushalta Academy
John Bhatt
 
Universal Design, Education and Technology
Universal Design, Education and TechnologyUniversal Design, Education and Technology
Universal Design, Education and TechnologyDamian T. Gordon
 
Youtube Policy Primer
Youtube Policy PrimerYoutube Policy Primer
Youtube Policy Primer
ESutton17
 
BPCO IPERTENSIONE POLMONARE-PH COPD
BPCO IPERTENSIONE POLMONARE-PH COPDBPCO IPERTENSIONE POLMONARE-PH COPD
BPCO IPERTENSIONE POLMONARE-PH COPD
PAHUPDATE
 
Training ime, guru
Training ime, guruTraining ime, guru
Training ime, guruimecommunity
 
fall meeting sept 18-21, 2007 version 2
fall meeting sept 18-21, 2007 version 2fall meeting sept 18-21, 2007 version 2
fall meeting sept 18-21, 2007 version 2Philip Young
 
Eziopatogenesi Ipertensione Polmonare Arteriosa-PAH ETIOPATHOGENESIS
Eziopatogenesi Ipertensione Polmonare Arteriosa-PAH ETIOPATHOGENESISEziopatogenesi Ipertensione Polmonare Arteriosa-PAH ETIOPATHOGENESIS
Eziopatogenesi Ipertensione Polmonare Arteriosa-PAH ETIOPATHOGENESISPAHUPDATE
 
Large organisations large intranets: where to start a redevelopment project
Large organisations large intranets: where to start a redevelopment projectLarge organisations large intranets: where to start a redevelopment project
Large organisations large intranets: where to start a redevelopment project
Tamsin Stanford
 
Inleiding Milieurecht
Inleiding MilieurechtInleiding Milieurecht
Inleiding Milieurecht
devalk137
 
វចនានុក្រុម ពេទ្យ អង់គ្លេស ខ្មែរ
វចនានុក្រុម ពេទ្យ អង់គ្លេស   ខ្មែរវចនានុក្រុម ពេទ្យ អង់គ្លេស   ខ្មែរ
វចនានុក្រុម ពេទ្យ អង់គ្លេស ខ្មែរ
Channa Khieng
 

Viewers also liked (17)

Bridge metrics channel marketing overview 2013
Bridge metrics channel marketing overview 2013Bridge metrics channel marketing overview 2013
Bridge metrics channel marketing overview 2013
 
Cognitivism
CognitivismCognitivism
Cognitivism
 
Steel sm
Steel smSteel sm
Steel sm
 
Television Cameras puzzle
Television Cameras puzzleTelevision Cameras puzzle
Television Cameras puzzle
 
Corporate training - Mind Programming - Kushalta Academy
Corporate training - Mind Programming - Kushalta AcademyCorporate training - Mind Programming - Kushalta Academy
Corporate training - Mind Programming - Kushalta Academy
 
100 examples
100 examples100 examples
100 examples
 
Universal Design, Education and Technology
Universal Design, Education and TechnologyUniversal Design, Education and Technology
Universal Design, Education and Technology
 
Steel
SteelSteel
Steel
 
Youtube Policy Primer
Youtube Policy PrimerYoutube Policy Primer
Youtube Policy Primer
 
BPCO IPERTENSIONE POLMONARE-PH COPD
BPCO IPERTENSIONE POLMONARE-PH COPDBPCO IPERTENSIONE POLMONARE-PH COPD
BPCO IPERTENSIONE POLMONARE-PH COPD
 
Training ime, guru
Training ime, guruTraining ime, guru
Training ime, guru
 
fall meeting sept 18-21, 2007 version 2
fall meeting sept 18-21, 2007 version 2fall meeting sept 18-21, 2007 version 2
fall meeting sept 18-21, 2007 version 2
 
Eziopatogenesi Ipertensione Polmonare Arteriosa-PAH ETIOPATHOGENESIS
Eziopatogenesi Ipertensione Polmonare Arteriosa-PAH ETIOPATHOGENESISEziopatogenesi Ipertensione Polmonare Arteriosa-PAH ETIOPATHOGENESIS
Eziopatogenesi Ipertensione Polmonare Arteriosa-PAH ETIOPATHOGENESIS
 
การใช้งานคอมฯ (Pptx)
การใช้งานคอมฯ  (Pptx)การใช้งานคอมฯ  (Pptx)
การใช้งานคอมฯ (Pptx)
 
Large organisations large intranets: where to start a redevelopment project
Large organisations large intranets: where to start a redevelopment projectLarge organisations large intranets: where to start a redevelopment project
Large organisations large intranets: where to start a redevelopment project
 
Inleiding Milieurecht
Inleiding MilieurechtInleiding Milieurecht
Inleiding Milieurecht
 
វចនានុក្រុម ពេទ្យ អង់គ្លេស ខ្មែរ
វចនានុក្រុម ពេទ្យ អង់គ្លេស   ខ្មែរវចនានុក្រុម ពេទ្យ អង់គ្លេស   ខ្មែរ
វចនានុក្រុម ពេទ្យ អង់គ្លេស ខ្មែរ
 

Similar to Entity Relationship Diagrams - Star Trek style

Uremic Pruritus (Basic Science → Evidence → Practice) - Dr. Gawad
Uremic Pruritus (Basic Science → Evidence → Practice) - Dr. GawadUremic Pruritus (Basic Science → Evidence → Practice) - Dr. Gawad
Uremic Pruritus (Basic Science → Evidence → Practice) - Dr. Gawad
NephroTube - Dr.Gawad
 
Case study-10-depression
Case study-10-depressionCase study-10-depression
Case study-10-depression
Ayesha Yaqoob
 
Dynamic Product Labeling Overview
Dynamic Product Labeling OverviewDynamic Product Labeling Overview
Dynamic Product Labeling Overview
Jon Duke, MD, MS
 
Journal.pctr.0020016.sd002
Journal.pctr.0020016.sd002Journal.pctr.0020016.sd002
Journal.pctr.0020016.sd002shafaat hussain
 
Case Representation on Typhoid
Case Representation on TyphoidCase Representation on Typhoid
Case Representation on Typhoid
Rushikesh shinde
 
Undifferentiated schizophrenia
Undifferentiated schizophreniaUndifferentiated schizophrenia
Undifferentiated schizophrenia
Oviyajp
 
Hypothyroidism - Nuts and Bolts
Hypothyroidism - Nuts and BoltsHypothyroidism - Nuts and Bolts
Hypothyroidism - Nuts and Bolts
Dr Karthik Balachandran
 

Similar to Entity Relationship Diagrams - Star Trek style (7)

Uremic Pruritus (Basic Science → Evidence → Practice) - Dr. Gawad
Uremic Pruritus (Basic Science → Evidence → Practice) - Dr. GawadUremic Pruritus (Basic Science → Evidence → Practice) - Dr. Gawad
Uremic Pruritus (Basic Science → Evidence → Practice) - Dr. Gawad
 
Case study-10-depression
Case study-10-depressionCase study-10-depression
Case study-10-depression
 
Dynamic Product Labeling Overview
Dynamic Product Labeling OverviewDynamic Product Labeling Overview
Dynamic Product Labeling Overview
 
Journal.pctr.0020016.sd002
Journal.pctr.0020016.sd002Journal.pctr.0020016.sd002
Journal.pctr.0020016.sd002
 
Case Representation on Typhoid
Case Representation on TyphoidCase Representation on Typhoid
Case Representation on Typhoid
 
Undifferentiated schizophrenia
Undifferentiated schizophreniaUndifferentiated schizophrenia
Undifferentiated schizophrenia
 
Hypothyroidism - Nuts and Bolts
Hypothyroidism - Nuts and BoltsHypothyroidism - Nuts and Bolts
Hypothyroidism - Nuts and Bolts
 

More from Damian T. Gordon

Universal Design for Learning, Co-Designing with Students.
Universal Design for Learning, Co-Designing with Students.Universal Design for Learning, Co-Designing with Students.
Universal Design for Learning, Co-Designing with Students.
Damian T. Gordon
 
Introduction to Microservices
Introduction to MicroservicesIntroduction to Microservices
Introduction to Microservices
Damian T. Gordon
 
REST and RESTful Services
REST and RESTful ServicesREST and RESTful Services
REST and RESTful Services
Damian T. Gordon
 
Serverless Computing
Serverless ComputingServerless Computing
Serverless Computing
Damian T. Gordon
 
Cloud Identity Management
Cloud Identity ManagementCloud Identity Management
Cloud Identity Management
Damian T. Gordon
 
Containers and Docker
Containers and DockerContainers and Docker
Containers and Docker
Damian T. Gordon
 
Introduction to Cloud Computing
Introduction to Cloud ComputingIntroduction to Cloud Computing
Introduction to Cloud Computing
Damian T. Gordon
 
Introduction to ChatGPT
Introduction to ChatGPTIntroduction to ChatGPT
Introduction to ChatGPT
Damian T. Gordon
 
How to Argue Logically
How to Argue LogicallyHow to Argue Logically
How to Argue Logically
Damian T. Gordon
 
Evaluating Teaching: SECTIONS
Evaluating Teaching: SECTIONSEvaluating Teaching: SECTIONS
Evaluating Teaching: SECTIONS
Damian T. Gordon
 
Evaluating Teaching: MERLOT
Evaluating Teaching: MERLOTEvaluating Teaching: MERLOT
Evaluating Teaching: MERLOT
Damian T. Gordon
 
Evaluating Teaching: Anstey and Watson Rubric
Evaluating Teaching: Anstey and Watson RubricEvaluating Teaching: Anstey and Watson Rubric
Evaluating Teaching: Anstey and Watson Rubric
Damian T. Gordon
 
Evaluating Teaching: LORI
Evaluating Teaching: LORIEvaluating Teaching: LORI
Evaluating Teaching: LORI
Damian T. Gordon
 
Designing Teaching: Pause Procedure
Designing Teaching: Pause ProcedureDesigning Teaching: Pause Procedure
Designing Teaching: Pause Procedure
Damian T. Gordon
 
Designing Teaching: ADDIE
Designing Teaching: ADDIEDesigning Teaching: ADDIE
Designing Teaching: ADDIE
Damian T. Gordon
 
Designing Teaching: ASSURE
Designing Teaching: ASSUREDesigning Teaching: ASSURE
Designing Teaching: ASSURE
Damian T. Gordon
 
Designing Teaching: Laurilliard's Learning Types
Designing Teaching: Laurilliard's Learning TypesDesigning Teaching: Laurilliard's Learning Types
Designing Teaching: Laurilliard's Learning Types
Damian T. Gordon
 
Designing Teaching: Gagne's Nine Events of Instruction
Designing Teaching: Gagne's Nine Events of InstructionDesigning Teaching: Gagne's Nine Events of Instruction
Designing Teaching: Gagne's Nine Events of Instruction
Damian T. Gordon
 
Designing Teaching: Elaboration Theory
Designing Teaching: Elaboration TheoryDesigning Teaching: Elaboration Theory
Designing Teaching: Elaboration Theory
Damian T. Gordon
 
Universally Designed Learning Spaces: Some Considerations
Universally Designed Learning Spaces: Some ConsiderationsUniversally Designed Learning Spaces: Some Considerations
Universally Designed Learning Spaces: Some Considerations
Damian T. Gordon
 

More from Damian T. Gordon (20)

Universal Design for Learning, Co-Designing with Students.
Universal Design for Learning, Co-Designing with Students.Universal Design for Learning, Co-Designing with Students.
Universal Design for Learning, Co-Designing with Students.
 
Introduction to Microservices
Introduction to MicroservicesIntroduction to Microservices
Introduction to Microservices
 
REST and RESTful Services
REST and RESTful ServicesREST and RESTful Services
REST and RESTful Services
 
Serverless Computing
Serverless ComputingServerless Computing
Serverless Computing
 
Cloud Identity Management
Cloud Identity ManagementCloud Identity Management
Cloud Identity Management
 
Containers and Docker
Containers and DockerContainers and Docker
Containers and Docker
 
Introduction to Cloud Computing
Introduction to Cloud ComputingIntroduction to Cloud Computing
Introduction to Cloud Computing
 
Introduction to ChatGPT
Introduction to ChatGPTIntroduction to ChatGPT
Introduction to ChatGPT
 
How to Argue Logically
How to Argue LogicallyHow to Argue Logically
How to Argue Logically
 
Evaluating Teaching: SECTIONS
Evaluating Teaching: SECTIONSEvaluating Teaching: SECTIONS
Evaluating Teaching: SECTIONS
 
Evaluating Teaching: MERLOT
Evaluating Teaching: MERLOTEvaluating Teaching: MERLOT
Evaluating Teaching: MERLOT
 
Evaluating Teaching: Anstey and Watson Rubric
Evaluating Teaching: Anstey and Watson RubricEvaluating Teaching: Anstey and Watson Rubric
Evaluating Teaching: Anstey and Watson Rubric
 
Evaluating Teaching: LORI
Evaluating Teaching: LORIEvaluating Teaching: LORI
Evaluating Teaching: LORI
 
Designing Teaching: Pause Procedure
Designing Teaching: Pause ProcedureDesigning Teaching: Pause Procedure
Designing Teaching: Pause Procedure
 
Designing Teaching: ADDIE
Designing Teaching: ADDIEDesigning Teaching: ADDIE
Designing Teaching: ADDIE
 
Designing Teaching: ASSURE
Designing Teaching: ASSUREDesigning Teaching: ASSURE
Designing Teaching: ASSURE
 
Designing Teaching: Laurilliard's Learning Types
Designing Teaching: Laurilliard's Learning TypesDesigning Teaching: Laurilliard's Learning Types
Designing Teaching: Laurilliard's Learning Types
 
Designing Teaching: Gagne's Nine Events of Instruction
Designing Teaching: Gagne's Nine Events of InstructionDesigning Teaching: Gagne's Nine Events of Instruction
Designing Teaching: Gagne's Nine Events of Instruction
 
Designing Teaching: Elaboration Theory
Designing Teaching: Elaboration TheoryDesigning Teaching: Elaboration Theory
Designing Teaching: Elaboration Theory
 
Universally Designed Learning Spaces: Some Considerations
Universally Designed Learning Spaces: Some ConsiderationsUniversally Designed Learning Spaces: Some Considerations
Universally Designed Learning Spaces: Some Considerations
 

Recently uploaded

Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
Celine George
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024
ak6969907
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
NelTorrente
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
Dr. Shivangi Singh Parihar
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Akanksha trivedi rama nursing college kanpur.
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
Celine George
 

Recently uploaded (20)

Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
 

Entity Relationship Diagrams - Star Trek style

  • 2.  
  • 3.  
  • 4.  
  • 7. Prescription Dr. Lewis Zimmerman 459 Patient name: Tom Paris Stardate: 41153.7 Drug: Tri-Ox Compound Take twice a day Dr. Lewis Zimmerman 459 Patient name: Tom Paris Stardate: 41153.7 Drug: Tri-Ox Compound Take twice a day
  • 8. Prescription Dr. Lewis Zimmerman 459 Patient name: Tom Paris Stardate: 41153.7 Drug: Tri-Ox Compound Take twice a day Doctor Patient Date Drug Frequency Prescription number Dr. Lewis Zimmerman 459 Patient name: Tom Paris Stardate: 41153.7 Drug: Tri-Ox Compound Take twice a day
  • 9. Prescription PrescriptionID DoctorName PatientName DrugName Date Frequency
  • 10. Prescription PrescriptionID DoctorName PatientName DrugName Date Frequency Is this a good and sufficient representation ?????
  • 11. Prescription 3 37389.5 Tri-Ox T’Pol Dr. Phlox 9 4 45673.4 Hyronalin Katherine Janeway Dr. L. Zimmerman 8 5 42604.4 Tri-Ox Tom Paris Dr. Lewis Zimmerman 7 90 42765.5 Priaxate Tom Paris L. Zimmerman 6 2 48796.6 Synaptizine Odo Dr. Bashir 5 1 45912.3 Hyronalin Lt. Data Dr. Beverly Crusher 4 7 42235.2 Tri-Ox Harry Kim Lewis Zimmerman 3 3 45432.1 Hyronalin Odo Dr. Julian Bashir 2 2 42231.2 Tri-Ox Tom Paris Dr. Lewis Zimmerman 1 Frequency (per day) Date Drug Name Patient Name Doctor Name Prescription ID
  • 12.
  • 13.
  • 14.
  • 15. Prescription 3 37389.5 Tri-Ox T’Pol Dr. Phlox 9 4 45673.4 Hyronalin Katherine Janeway Dr. L. Zimmerman 8 5 42604.4 Tri-Ox Tom Paris Dr. Lewis Zimmerman 7 90 42765.5 Priaxate Tom Paris L. Zimmerman 6 2 48796.6 Synaptizine Odo Dr. Bashir 5 1 45912.3 Hyronalin Lt. Data Dr. Beverly Crusher 4 7 42235.2 Tri-Ox Harry Kim Lewis Zimmerman 3 3 45432.1 Hyronalin Odo Dr. Julian Bashir 2 2 42231.2 Tri-Ox Tom Paris Dr. Lewis Zimmerman 1 Frequency (per day) Date Drug Name Patient Name Doctor Name Prescription ID
  • 16. Prescription 3 37389.5 Tri-Ox T’Pol 4 9 4 45673.4 Hyronalin Katherine Janeway 1 8 5 42604.4 Tri-Ox Tom Paris 1 7 90 42765.5 Priaxate Tom Paris 1 6 2 48796.6 Synaptizine Odo 2 5 1 45912.3 Hyronalin Lt. Data 2 4 7 42235.2 Tri-Ox Harry Kim 1 3 3 45432.1 Hyronalin Odo 2 2 2 42231.2 Tri-Ox Tom Paris 1 1 Frequency (per day) Date Drug Name Patient Name Doctor ID Prescription ID
  • 17.
  • 18. Prescription 3 37389.5 Tri-Ox T’Pol 4 9 4 45673.4 Hyronalin Katherine Janeway 1 8 5 42604.4 Tri-Ox Tom Paris 1 7 90 42765.5 Priaxate Tom Paris 1 6 2 48796.6 Synaptizine Odo 2 5 1 45912.3 Hyronalin Lt. Data 2 4 7 42235.2 Tri-Ox Harry Kim 1 3 3 45432.1 Hyronalin Odo 2 2 2 42231.2 Tri-Ox Tom Paris 1 1 Frequency (per day) Date Drug Name Patient Name Doctor ID Prescription ID
  • 19. Prescription 3 37389.5 Tri-Ox 6 4 9 4 45673.4 Hyronalin 5 1 8 5 42604.4 Tri-Ox 1 1 7 90 42765.5 Priaxate 1 1 6 2 48796.6 Synaptizine 2 2 5 1 45912.3 Hyronalin 4 2 4 7 42235.2 Tri-Ox 3 1 3 3 45432.1 Hyronalin 2 2 2 2 42231.2 Tri-Ox 1 1 1 Frequency (per day) Date Drug Name Patient ID Doctor ID Prescription ID
  • 20.
  • 21. Prescription 3 37389.5 Tri-Ox 6 4 9 4 45673.4 Hyronalin 5 1 8 5 42604.4 Tri-Ox 1 1 7 90 42765.5 Priaxate 1 1 6 2 48796.6 Synaptizine 2 2 5 1 45912.3 Hyronalin 4 2 4 7 42235.2 Tri-Ox 3 1 3 3 45432.1 Hyronalin 2 2 2 2 42231.2 Tri-Ox 1 1 1 Frequency (per day) Date Drug Name Patient ID Doctor ID Prescription ID
  • 22. Prescription 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID
  • 23.
  • 24. Prescription Drug Patient Doctor 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman 1 Doctor Name Doctor ID
  • 26.
  • 27. Prescription Drug Patient Doctor 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman 1 Doctor Name Doctor ID
  • 28. Prescription Drug Patient Doctor Text Numbers Text Text 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman 1 Doctor Name Doctor ID
  • 29. Prescription Drug Patient Doctor Transactional Table Master Table Master Table Master Table 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman 1 Doctor Name Doctor ID
  • 30.
  • 31. Prescription Drug Patient Doctor 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman 1 Doctor Name Doctor ID
  • 32. Prescription Drug Patient Doctor Tricordrazine 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman 1 Doctor Name Doctor ID
  • 33.
  • 34. Prescription 3 37389.5 Tri-Ox T’Pol Dr. Phlox 9 4 45673.4 Hyronalin Katherine Janeway Dr. L. Zimmerman 8 5 42604.4 Tri-Ox Tom Paris Dr. Lewis Zimmerman 7 90 42765.5 Priaxate Tom Paris L. Zimmerman 6 2 48796.6 Synaptizine Odo Dr. Bashir 5 1 45912.3 Hyronalin Lt. Data Dr. Beverly Crusher 4 7 42235.2 Tri-Ox Harry Kim Lewis Zimmerman 3 3 45432.1 Hyronalin Odo Dr. Julian Bashir 2 2 42231.2 Tri-Ox Tom Paris Dr. Lewis Zimmerman 1 Frequency (per day) Date Drug Name Patient Name Doctor Name Prescription ID
  • 35. Prescription Tricordrazine Tricordrazine Tricordrazine Tricordrazine 3 37389.5 Tri-Ox T’Pol Dr. Phlox 9 4 45673.4 Hyronalin Katherine Janeway Dr. L. Zimmerman 8 5 42604.4 Tri-Ox Tom Paris Dr. Lewis Zimmerman 7 90 42765.5 Priaxate Tom Paris L. Zimmerman 6 2 48796.6 Synaptizine Odo Dr. Bashir 5 1 45912.3 Hyronalin Lt. Data Dr. Beverly Crusher 4 7 42235.2 Tri-Ox Harry Kim Lewis Zimmerman 3 3 45432.1 Hyronalin Odo Dr. Julian Bashir 2 2 42231.2 Tri-Ox Tom Paris Dr. Lewis Zimmerman 1 Frequency (per day) Date Drug Name Patient Name Doctor Name Prescription ID
  • 36.
  • 37. Prescription Tricordrazine Tricordrazine Tricordrazine 3 37389.5 Tri-Ox T’Pol Dr. Phlox 9 4 45673.4 Hyronalin Katherine Janeway Dr. L. Zimmerman 8 5 42604.4 Tri-Ox Tom Paris Dr. Lewis Zimmerman 7 90 42765.5 Priaxate Tom Paris L. Zimmerman 6 2 48796.6 Synaptizine Odo Dr. Bashir 5 1 45912.3 Hyronalin Lt. Data Dr. Beverly Crusher 4 7 42235.2 Tri-Ox Harry Kim Lewis Zimmerman 3 3 45432.1 Hyronalin Odo Dr. Julian Bashir 2 2 42231.2 Tri-Ox Tom Paris Dr. Lewis Zimmerman 1 Frequency (per day) Date Drug Name Patient Name Doctor Name Prescription ID
  • 38.
  • 39.
  • 40. Prescription Drug Patient Doctor 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman 1 Doctor Name Doctor ID
  • 41. Now when we insert a record
  • 42. Now when we insert a record PrescriptionID DoctorID PatientID DrugID Date Frequency
  • 43. Prescription Insert new prescription record
  • 44. Prescription Insert new prescription record Drug Check if the drug on the prescription is a real and existing drug
  • 45. Prescription Drug Insert new prescription record Patient Check if the patient on the prescription is a real and existing patient
  • 46. Prescription Drug Insert new prescription record Patient Check if the doctor on the Prescription is a real and existing doctor Doctor
  • 48. Prescription Drug Patient Doctor DrugID PatientID DoctorID
  • 49. Prescription Drug Patient Doctor DrugID PatientID DoctorID PrescriptionID DoctorID PatientID DrugID Date Frequency DrugID DrugName RecommendedDosage Side-Effects PatientID PatientName PatientAddress Sympthoms Occupation DoctorID DoctorName Qualifications
  • 50. Prescription Drug Patient Doctor DrugID PatientID DoctorID PrescriptionID DoctorID PatientID DrugID Date Frequency DrugID DrugName RecommendedDosage Side-Effects DoctorID DoctorName Qualifications PatientID PatientName PatientAddress Sympthoms Occupation
  • 51.